LONGDOM takes the privilege to invite all the participants, speakers, students, delegates, sponsors, exhibitors from all over the world to attend World Summit on Infectious Diseases and Therapeutics which is going to be held on July 30-31, 2021 in Paris, France. Infectious Diseases 2021 will be organized under the theme " Strategies & Innovative Techniques to diagnose, prevent and treat Infectious Diseases " which covers wide range of critically important sessions and the main goal of this conference is to provide a transformative professional development experience through informative keynote lectures, workshops, poster presentations in the field of Infectious Diseases. We would like you to share, extend and impart your valuable thoughts to the global scientific event set to happen in Paris this year as we start to prepare the dais for a grand discussion.
LONGDOM conferences speaker bureau map future challenges through ideation sessions by designing and validating new ideas with end users by placing right speakers in front of right audience at the right time.
Haluskova Balter Ivana, MD, France
French Medical professional specialized in infectious diseases, internal medicine covering various therapeutic axes, certified in Immunology and Pediatric, MBA vaccinology and years of active clinical practice. Certified in Health and diplomacy (Geneve) Lived multi-country medical “field “experience in Southeast Asia (India in particular), West/Central/East Europe. Speaking French, English, Russian, Italian, Czech, Slovak with notion of Mandarin.
Over 15 years of experience in senior position in various industry companies in research and development for European and USA for vaste and complexe international programs and therapeutic areas for adults and children including infectious and tropical diseases, vaccins, metabolic and CVS, neurodegenerative diseases,inflammation, onco/oncoimmunology and orphan indications. Active member of World alliance against antibiotic resistance (Administrative board) and French immunology society (SFI) administrative board and several international academic societies (focus on innovation of R&D reflecting immunology and genetic variability, role of immunologic approach for treatment and diagnostic, tackle problem of resistance for antimicrobials(TB including), antiparasisitc, antivirals etc using multiple approach and linking multiple partners in concept of One health.
Dr. Leon G. Leanse is currently appointed as a research fellow at Harvard Medical School working within the Wellman Center for Photomedicine at Massachusetts General Hospital. He is a molecular microbiologist by training, with an MSc from the London School of Hygiene and Tropical Medicine and a PhD in molecular microbiology from Imperial College London. Dr. Leanse’s research is current is currently focused on synergistic light-antimicrobial interactions for the elimination of multidrug resistant localized infections.
Stefania Lauzi is a Veterinarian, University Researcher of the Veterinary Medicine Department, University of Milan, Italy. Specialist in Animal health, breeding and production, in the field of Public Health and Infectious diseases of animals, her scientific and research activity focused on the epidemiology and molecular diagnostics of zoonoses and bacterial and viral veterinary infectious diseases such as bovine tuberculosis, bovine viral diarrhea virus, vector-borne pathogens, feline coronavirus, feline morbillivirus and colibacillosis. To date her studies and activities are also focused on the influence of the microbiome on animal diseases. She is author and co-author of several publications on national and international scientific peer-reviewed journals. She is also teacher of university courses on emerging zoonoses and infectious diseases in animals for Veterinary Medicine degree students and for post-graduate students at the University of Milan, Italy.
International Public Health Specialist with more than twelve years of experience in humanitarian affairs associated with Maternal, New born and Child Health (MNCH), Research, Project Monitoring and Evaluation, Health System Strengthening, Quality Assurance and Capacity Building, with teaching/mentoring experience for public health students, staff and volunteers. He worked for Doctors with Africa – CUAMM Lake state, South Sudan as Technical Project Manager where he was responsible for providing leadership and overall guidance in project planning, implementation and monitoring/evaluation including direct technical support; (training and mentoring) to staff, towards achieving effective participatory and sustainable implementation, of primary and secondary health care system at all levels. He presently works Health Support Organaization – THESO as Country Program Director, South Sudan.
Dr. Nebiyu has been involved in many public health field works and operational researches. He has research publications on various medical and public health issues to his credit. He is known for commitment to excellence that is evident through all aspects of his work. He is innovative, demonstrates respect for others, passionate about his work and has a strong sense of accountability. His contributions have helped dramatically improve the reproductive health, child health, Expanded Program on Immunization (EPI), surveillance, prevention and treatment of Communicable and Non-Communicable Diseases (NCDs), health promotion, nutrition therapy program (as funded by USAID, HPF, WFP, UNICEF, Japan Plat fourm and Italian Cooperation funds) including evaluation system in South Sudan.
Julia Duffey is a virologist and medical communicator and works as a Director of Global Strategy in infectious diseases for Medscape/WebMD. She holds a BSc and MSc in Medical Microbiology and a PhD in Virology. Julia has over 12 years experience in medical communications and medical education. She has been heavily involved in developing the strategy and concepts for Medscape’s independent medical education on COVID-19, multi-drug resistant Gram-negative bacteria, invasive fungal infections, HIV, immunizations, hepatitis C and B. Julia has recently presented two posters as Glasgow HIV 2020 and ECCMID 2020. Julia grew up and continues to raise a family in the Peak District National Park in the UK and is passionate about virology and the appropriate communication of scientific data.
Abdul Hameed is currently appointed as an Infection preventionist at CDC Foundation, recently completed master’s degree in public health from University of Massachusetts Lowell in May 2020. Before that he completed his Doctor of Physical therapy degree in 2017 from Dow University of health Sciences, Pakistan. Over two years' experience in the field of Healthcare, currently he is based in the Minnesota Department of Health, where he conducts infection control and response assessments with the facilities all over Minnesota. He writes facility reports and provide education to individuals and groups about risk, prevention, transmission, and control of COVID-19 and other diseases. He also reviews State, CDC, CMS guidelines and evidence-based practices and incorporate appropriate findings into routine practice.
Ricardo Bezerra Requião is Business Manager by profession and works at Roche for 5 years now. He holds a double degree in International Relations and Business Management, and a M.A. of International Relations, is author of two published books and a few articles on International Migration Theory and Migration Policies. Experienced in marketing and product lifecycle management, commercial strategy development and PMO, in companies within and outside the pharma industry. At Roche, previously as Manager for HCP Solutions, Ricardo was accountable for proposing and supporting the branding teams to deliver value, through differentiated solutions, to key stakeholders. Currently, is responsible for Management of Brand Strategies for Patients with COVID-19, Rheumatic Diseases and Gynaecological Cancers; in the Public and Private Markets. Passionate of learning, Ricardo is also an enthusiast of coffee, books and traveling, and currently lives in São Paulo, Brazil.
Dr. Dorkina Carmell Myrick is an accomplished leader, physician, scientist, policymaker, writer, and future attorney at the Boston University School of Law with work experience in the governments of the United States (judicial, legislative, and executive branches) and the United Kingdom.
Dr. Myrick worked as a judicial extern at the United States District Court of the District of Massachusetts for the Honorable William G. Young. Immediately prior to this, Dr. Myrick worked as a judicial intern for the Honorable O. Rogeriee Thompson at the United States First Circuit Court of Appeals.
While at the University of Oxford, Dr. Myrick worked as a Global Health Policy Consultant for Dame Sally Davies, Chief Medical Officer of England, at the Department of Health in the United Kingdom. While there, Dr. Myrick formulated recommendations to combat antimicrobial resistance for submission to the United Nations General Assembly Meeting on antimicrobial resistance in September 2016.
Dr. Myrick worked in the United States Senate as a Brookings Institution Congressional Fellow for Senator Patty Murray on the Senate Committee on Veterans’ Affairs and as a Senior Health Policy Advisor for Senator Bill Nelson on the Senate Special Committee on Aging. She also worked as a health staffer in the United States House of Representatives. In addition, Dr. Myrick worked on political campaigns for Senators Edward Markey and Cory Booker.
Dr. Myrick worked at the National Institutes of Health during the administrations of President George W. Bush and President Barack H. Obama, where she received a 10-year National Cancer Institute Director's Award for her service. Dr. Myrick managed and provided program oversight for over $252 million in National Institutes of Health research grants in basic science, clinical, and translational research housed at medical centers and academic research institutions nation-wide.
Dr. Myrick earned M.D. and Ph.D. degrees from Brown University School of Medicine as the first African-American to complete the M.D.-Ph.D. program. Dr. Myrick completed a medical residency in Pathology at the National Cancer Institute of the National Institutes of Health. She also holds a Master of Public Policy from the University of Oxford, a Certificate in Public Leadership from the Brookings Institution, and a Certificate in Legislative Studies from Georgetown University. Dr. Myrick received a B.S. in Biology from Prairie View A & M University. Dr. Myrick is interested in international issues at the intersection of medicine, research, innovation, law, and policy.
Dr. Dorkina Carmell Myrick is an accomplished leader, physician, scientist, policymaker, writer, and future attorney at the Boston University School of Law with work experience in the governments of the United States (judicial, legislative, and executive branches) and the United Kingdom.
Dr. Myrick worked as a judicial extern at the United States District Court of the District of Massachusetts for the Honorable William G. Young. Immediately prior to this, Dr. Myrick worked as a judicial intern for the Honorable O. Rogeriee Thompson at the United States First Circuit Court of Appeals.
While at the University of Oxford, Dr. Myrick worked as a Global Health Policy Consultant for Dame Sally Davies, Chief Medical Officer of England, at the Department of Health in the United Kingdom. While there, Dr. Myrick formulated recommendations to combat antimicrobial resistance for submission to the United Nations General Assembly Meeting on antimicrobial resistance in September 2016.
Dr. Myrick worked in the United States Senate as a Brookings Institution Congressional Fellow for Senator Patty Murray on the Senate Committee on Veterans’ Affairs and as a Senior Health Policy Advisor for Senator Bill Nelson on the Senate Special Committee on Aging. She also worked as a health staffer in the United States House of Representatives. In addition, Dr. Myrick worked on political campaigns for Senators Edward Markey and Cory Booker.
Dr. Myrick worked at the National Institutes of Health during the administrations of President George W. Bush and President Barack H. Obama, where she received a 10-year National Cancer Institute Director's Award for her service. Dr. Myrick managed and provided program oversight for over $252 million in National Institutes of Health research grants in basic science, clinical, and translational research housed at medical centers and academic research institutions nation-wide.
Dr. Myrick earned M.D. and Ph.D. degrees from Brown University School of Medicine as the first African-American to complete the M.D.-Ph.D. program. Dr. Myrick completed a medical residency in Pathology at the National Cancer Institute of the National Institutes of Health. She also holds a Master of Public Policy from the University of Oxford, a Certificate in Public Leadership from the Brookings Institution, and a Certificate in Legislative Studies from Georgetown University. Dr. Myrick received a B.S. in Biology from Prairie View A & M University. Dr. Myrick is interested in international issues at the intersection of medicine, research, innovation, law, and policy.
Dr. Gamal M. Saied received his MBBch with Honor in 1969 and Diploma in General Surgery in 1971 and his MD in general Surgery in 1977 from the Faculty of medicine Cairo University in Egypt. He was then indulged in multitudes of academic, administrative and scientific posts until occupying the position of the Head of Surgical Oncology Unit 27 B [Cairo University Hospitals] for continuous 4 years ending in August 2007. During this march he was decorated the Award of State in medical sciences in 1988 and the Laureate of Excellence [First Class] from the President of Egypt in 1995 .He is now a Member of the European Association for Cancer Research ASCO ( USA) , EACR and NESA (Europe) . Prof. Saied is also a member of many scientific, academic and researches Assemblies affiliated to the Supreme Councils of Universities [Ministry of Higher Education] and the Ministry of Public Health & Population in Egypt.
Dr. Jimmy Kayastha graduated from Nova Southeastern University, Florida, where he completed his post-graduate Residency in Advanced Education in General Dentistry (AEGD I and II). He completed his General Practice Residency at Miami Valley Hospital, Ohio, Oral Medicine Residency at Carolinas Medical Center, North Carolina and Glasgow Dental Hospital, United Kingdom. He then completed his surgical Fellowship from America’s second best hospital, The Cleveland Clinic and Orofacial Pain Fellowship from Walter Reed National Military Medical Center, best known as the U.S. President’s Hospital.
Dr. Kayastha is board certified and has 18 years of experience in the U.S. He has served as the Director, AEGD Residency Program; U.S. NIDCR funded Post-Doctoral Research Scientist, Marshfield Clinic, Wisconsin; Adjunct Clinical Faculty, Case Western Reserve University and Miami Valley Hospital, Ohio. He was appointed to serve on the Executive Leadership Board at the International Society for Quality and Safety in Healthcare in London, England.
Dr. Kayastha has had scientific publications in the Journal American Medical Informatics Association (JAMIA), Journal American Clinical Medicine Research (JACMR), Journal American Dental Association (JADA), Journal of Oral Surgery, Oral Medicine, Oral Pathology and Radiology (OOOO). He has co-authored an eBook ‘Biomaterials being used in Oral and Maxillofacial Surgery’ and is a regular Op-Ed contributor for The New York Times.
Dr. Kayastha specializes in digital implant guided surgery, bone and sinus augmentation, full-mouth rehabilitation, medical and surgical management of maxillofacial pathologies, interdisciplinary management of medically complex patients, maxillofacial oncology, facial neuropathies, salivary gland diseases, temporomandibular disorders, orofacial pain and trauma, geriatrics and special needs dentistry, conscious sedation, CAD-CAM technology, HIT, biomedical informatics and clinical research
Prof. Dr Kazi Abdul Mannan is an Adjunct Professor of Faculty of Business Studies in Bangladesh and is currently the Director of the Migration Research and Development Society of Bangladesh (MRDSB) and Center for Academic & Professional Career Development and Research (CAPCDR). He obtained the B.Com, BA, LLB and the M.Com (Marketing) from the University of Dhaka and Doctor of Business Administration (DBA) from the Southern Cross University, Australia. In 1995, he joined the Institute of Business Studies, Moscow, as a Lecturer. Since 2005, he has been with the same Institute, where he was an Assistant Professor, and became an Associate Professor in 2000, and moved to University Uttara as a Professor. His research interests include migration, diaspora, remittance, business and public health. He has published books and has almost one hundred conference papers, articles in National and International Journals. His research interests include, Migrations, and Remittances.
Dr. Hari Mohan Saxena earned a PhD degree in Immunology from the University of Nottingham, UK. He was a recipient of the prestigious Jawahar Lal Nehru Scholarship of the Nehru Trust, UK. Dr. Saxena recently retired as a Professor of Immunology from GADVASU, Ludhiana where he was also the Head of the Veterinary Microbiology Department earlier. He has served as the Director (Resident Instructions) cum Dean, Postgraduate Studies and Director of Veterinary Clinical Complex at Bihar Animal Sciences University, Patna. He has also served as the Counsellor (Science & Technology) in the Embassy of India, Moscow (concurrently accredited to Ukraine and Belarus also). Dr. Saxena has been bestowed with the award of Fellow of Pearl Foundation for Education Excellence, Dr. S Radhakrishnan Lifetime Achievement National Award in teaching, Lifetime Education Excellence Award and Eminent Educationist Award. He was conferred National Excellence Award by Life Sciences Foundation, India, Lifetime Achievement Award in Veterinary Science by Venus International Foundation and International Distinguished Scientist Award by the World Research Council. He has obtained patents in USA, Europe, China, South Africa and India for his innovations in the diagnosis of infectious diseases.
Dr. Saxena is a Fellow of the World Innovation Foundation, UK, National Academy of Veterinary Sciences (India), Indian Society for Veterinary Immunology & Biotechnology (ISVIB), Indian Association of Applied Microbiologists, Society for Applied Biotechnology and Society for Scientific Development in Agriculture and Technology, respectively. He has won the F M Burnet Award, Scientist Award (twice), Mid-Career Scientist Award and Young Scientist Award of ISVIB. Dr. Saxena is a Senior Expert of the Asia Pacific CEO Association Worldwide and had been a Member of the Expert Panel on Vaccines of the European Society for Translational Medicine, a Member of the Steering Committee of the Science Advisory Board, USA and the President of the Indian Society for Veterinary Immunology & Biotechnology. He is a Member of Immunology Advisory Board of WebMedCentral (UK) and Immunology Editorial Board of WebMedCentral Plus, UK. He is the Editor of the Journal of Clinical Immunology and Immunopathology Research (published by Academic Journals, New York) and an Editorial Consultant of Indian Journal of Veterinary Research. He has served as a Review Editor of Frontiers in Immunology and Acta Scientific Microbiology. Dr. Saxena has done pioneering work in the diagnosis and therapy of Brucellosis and its non-invasive monitoring and assessment.
Noureddine EL AOUAD is a Professor at Abdel Malek Essâadi University in the Polydisciplinary Faculty of Larache-Tanger Morocco.
He is a Doctor in Natural products and bio-organic chemistry from Cadi Ayyad University, Marrakech-Morocco in 2002. After this date he has been working as a researcher at pharmacognosy and pharmacology department at the faculty of pharmacy of Valencia university in Spain. He had obtained a Master in rational use of drugs then another doctorate from the University of Valencia in Spain.
From 2010 to 2015 he had joint Foundation Medina (Center of excellence on natural products research) in Granada- Spain as a senior researcher working on the use of microbial cultures as a source of new bioactive molecules useful in anti-infective and anticancer therapies. From 2015 to 2020 he worked at Ibn Zohr University in Agadir for the last 5 years at the department of Chemistry as a Professor.
With more than 15 years of professional and academic experience in pharmacognosy, drug discovery, natural products and medicinal chemistry: isolation, structural elucidation of bioactive compounds from natural sources, Semi-synthesis, total synthesis and biological activities.
Hejer Harrabi is Born in 20 June 1980, Kairouan,Tunisia.
Medical Studies: University of Medicine Sfax, Tunisia; François Rabelais University of Tours, France; El Manar University Tunis, Tunisia
Diploma: Doctor in medicine in 2009, specialist in infectious diseases in 2010, University diploma (U.D) “Vaccinology”, U.D of Washington University “ Clinical Management of HIV”, UD “Reanimation in infectious diseases”, U.D “Antibiotherapy”, U.D “Geriatric medicine”, U.D. “Medical pedagogy”
Career: Referring doctor in infectious diseases and clinical researcher in the infectious diseases department, CHRU Tours, France (2009-2011); Public health doctor specialized in infectious diseases, CHU Ibn ElJazzar (2012-2014); University hospital assistant in the infectious diseases department, CHU La Rabta, El Manar University, Tunis (2014 - to now)
Articles: Chronic Hepatitis E and Immunosuppressive Therapy (N Engl J Med 2014), Uncomplicated urinary tract infection (N Engl J Med, 2012), Molecular diagnosis of Rickettsia infection in patients from Tunisia (Ticks Tick Borne Dis. 2016), A probably isolated subclavicular lymphadenopathy in acute leukemia: An unusual manifestation of cryptococcosis (Myc. Med 2010), Bilateral emphysematous pyelonephritis caused by Candida glabrata: An exceptional entity (J. Nephro 2010).
e-book: Tuberculous tenosynovitis: literature review (July 2016)
Priyatam khadka is a young, ebullient laboratory scientist; passionate on clinical microbiology, cell biology and cancer cell research; looking for a PhD. opportunity in the relevant topics of tropical and infectious disease, cancer cell and immune-therapy. Academically, he completed his Postgraduate in Medical Microbiology with a sound academic background. Currently, has been working as Medical Laboratory Professional in Tribhuvan University Teaching Hospital, Institute of Medicine, and Nepal for last 6 years and extra 3 yrs on other Health research institutes.
Princess Alexandra B. Duque-David completed Doctor of Medicine at the age of 24 years at Far Eastern University- NRMF, Quezon City, Philippines. Recently, completed her residency training in Pediatrics at Jose B. Lingad Memorial Regional Hospital, Pampanga, Philippines
Sladjana Pavic has been a specialist in infectious and tropical diseases and a master's degree in immunology since 2001. She has been employed at the Department of Infectious and Tropical Diseases of Uzice General Hospital since 1995, and since 2009 has been the department head. It is the only infectious disease treatment unit in the county with over 300,000 residents. During her many years of work, she has gained extensive experience in the diagnosis and treatment of patients with infectious diseases, as a ward doctor and as a consultant in other wards.
Sladjana Pavic is Chairman of the Ethics Committee of the Uzice Health Center, President of the Commission for Intrahospital Infections of Uzice General Hospital, Member of the Medicines Commission of Uzice General Hospital and member of the Uzice Health Center Council. She has participated in many domestic and international professional gatherings.
Raju Shrestha is a Microbiologist by profession and worked with one of the private pharmaceuticals in Nepal. He holds an M. Sc in Microbiology (Medical). Raju has 6 months of intenships in Department of Microbiology, Grande International Hospital, Nepal. He had also assisted PhD works of Lecturer and Assistant Professor. He has presented and attended different concerences in Nepal. Raju grew up in one of the middle class family of Nepal and is passionate about controlling infectious diseases.
Minkyung Seong is a laboratory scientist working at the UK national COVID-19 testing Lighthouse Laboratory in Cheshire. She holds a BSc in Animal Science and Biotechnology at Seoul National University in South Korea and recently finished a MSc degree in Medical Microbiology at the University of Manchester. She has extensive laboratory experience handling infectious diseases and particularly in identification/diagnosis of pathogens. She is self-driven and keen to challenge herself and conducted several self-designed projects about various topics including animal welfare during her undergraduate degree. As a scientist working at coronavirus related laboratory, Minkyung is highly interested in respiratory diseases.
Abdessamad AMINE is a Professor /researcher by profession and works in Faculty of science and techniques of Mohammedia (FSTM), university of Hassan II of Casablanca (UH2M, Morocco), and leader team of oncology and immunology in LBEA in the same faculty. He holds a BSc in Molecular Biology an biochemistry in FSTM, and his a Master of has his master's degree in radiopharmaceutical tracers from the Faculty of Pharmacy of René Descartes, University of Paris 5 in (France). Doctorat of philosophy degree in Radiobiology, biology molecular and genetics form Kremlin bicêtre school of medicine, University of Paris 11 (France). Pr. AMINE has 1 year of post doc followship in CEA (Central of nuclear energy) in Fontenay aux Roses (France).
Prof AMINE held the position of research professor at the FSTM for 11 years. at LBEA he is involved in several axes of research in oncology especially, such as HPV dependent cancer and the incidence of helicobacteria and the digestive system in Morocco. His research works are presented publicly in several national and international congresses
Having 17years public health background, Dr. Khan is a medical graduate, working in the division of Field Epidemiology & Disease Surveillance Division (FE&DSD) as Senior Field Epidemiologist dealing with infectious disease surveillance & outbreaks response at National Institute of Health (NIH). He is the Focal Person/team lead for IDSR since 2016 to work closely with Public Health England for designing and implementation of IDSRS in the country. He is also working as National Focal Person for Infection Prevention & Control. He is clinical coordinator and faculty member for FELTP Pakistan. He presented more than 10 abstracts in international conferences and got first prize in outbreak response activities during 4th EMPHNET conference.
Mr. Majid Tahir is working as Health Education & Risk Communication Officer by profession at National Institute of Health, Islamabad, Pakistan. Holds masters in social sciences and did Public Health Emergency Management Fellowship from CDC-ATL, United States. He has also been involved in public health emergency response activities to various outbreaks and public health issues in Pakistan. Recently engaged in COVID-19 response since January 2020. Developed National Risk Communication Plan for and its utilization in Public Health Emergency Operations Center.
We let our ground-breaking work and our amazing clients speak for us…… LONGDOM conferences